Literature DB >> 10063781

Limb salvage with Chopart's amputation and tendon balancing.

A M Reyzelman1, S Hadi, D G Armstrong.   

Abstract

For several decades, Chopart's amputation has met with some skepticism owing to reports of significant equinus deformity developing soon after the procedure is performed. However, with appropriate tendon balancing, which generally includes anterior tibial tendon transfer and tendo Achillis lengthening, this level of amputation is often more functional than slightly more distal amputations, such as Lisfranc or short transmetatarsal amputations. The authors offer a rationale for this observation, which includes a discussion of the longitudinal and transverse arch concept of the foot. This concept dictates that the shorter the midfoot-level amputation, the more likely the patient is to develop an equinovarus deformity, thus exposing the fifth metatarsal base and cuboid to weightbearing stress and a high risk of ulceration. Chopart's amputation, in eliminating the cuboid, often obviates the potential varus deformity and thus can have a more acceptable long-term result.

Entities:  

Mesh:

Year:  1999        PMID: 10063781     DOI: 10.7547/87507315-89-2-100

Source DB:  PubMed          Journal:  J Am Podiatr Med Assoc        ISSN: 1930-8264


  3 in total

1.  The use of a dermal substitute to preserve maximal foot length in diabetic foot wounds with tendon and bone exposure following urgent surgical debridement for acute infection.

Authors:  Giacomo Clerici; Maurizio Caminiti; Vincenzo Curci; Antonella Quarantiello; Ezio Faglia
Journal:  Int Wound J       Date:  2010-06       Impact factor: 3.315

2.  Predictive factors for successful limb salvage surgery in diabetic foot patients.

Authors:  Matthew Seung Suk Choi; Seung Bae Jeon; Jang Hyun Lee
Journal:  BMC Surg       Date:  2014-12-30       Impact factor: 2.102

3.  Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study.

Authors:  Ezio Faglia; Giacomo Clerici; Jacques Clerissi; Livio Gabrielli; Sergio Losa; Manuela Mantero; Maurizio Caminiti; Vincenzo Curci; Antonella Quarantiello; Tommaso Lupattelli; Tommaso Luppattelli; Alberto Morabito
Journal:  Diabetes Care       Date:  2009-02-17       Impact factor: 17.152

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.